Pharma Journalist - Page 780 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Lysogene completes Enrollment in SAMOS

Lysogene collaborates with Brammer Bio to produce LYS-GM101

USPTO issues Notice of Allowance to Neurana Pharmaceuticals for two new tolperisone patents

US FDA granted ODD for Abeona’s EB-101 gene therapy program

Optibrium and Imperial College Collaborate for Drug Development for Neglected Diseases as part of project with DNDi

US FDA ODAC recommends the approval of Pizer’s epoetin alfa biosimilar across all indications

X4 Pharmaceuticals Announces Study of X4P-001 in Patients with Advanced ccRCC

US FDA accepted Bristol-Myers Squibb supplemental BLA for use of Opdivo

Constellation Pharmaceuticals appoints Jigar Raythatha as President and CEO

Optum and Merck Collaborate to explore OBRSAs Performance Models